Shandong Weigao boosts treasury shares with recent buyback

Shandong Weigao Group Medical Polymer Company Limited completed a share repurchase on September 15, 2025, buying back 956,000 H shares for HK$5,576,224. The repurchase price per share ranged from HK$5.79 to HK$5.85, with a volume-weighted average of HK$5.8329.

Following this transaction, the company’s treasury shares increased to 18,377,200 from 17,421,200. The number of issued shares (excluding treasury shares) decreased to 4,503,955,124, while the total number of issued shares remains unchanged at 4,522,332,324.

This repurchase represents a 0.0212% change relative to the existing number of issued shares (excluding treasury shares) prior to the event. The company confirmed these shares will be held as treasury shares. The repurchase was executed on the Exchange and falls under a mandate granted on May 27, 2025, which authorized the company to repurchase up to 451,560,392 shares.

To date, the total number of shares repurchased under this mandate is 11,728,800, representing 2.5974% of the issued shares (excluding treasury shares) as of the mandate date. The moratorium period for any new share issues or transfers of treasury shares after this repurchase extends until October 15, 2025.